Jan D. Bos

12.7k total citations
131 papers, 9.3k citations indexed

About

Jan D. Bos is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Jan D. Bos has authored 131 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Dermatology, 73 papers in Immunology and 26 papers in Immunology and Allergy. Recurrent topics in Jan D. Bos's work include Dermatology and Skin Diseases (44 papers), T-cell and B-cell Immunology (35 papers) and Psoriasis: Treatment and Pathogenesis (32 papers). Jan D. Bos is often cited by papers focused on Dermatology and Skin Diseases (44 papers), T-cell and B-cell Immunology (35 papers) and Psoriasis: Treatment and Pathogenesis (32 papers). Jan D. Bos collaborates with scholars based in Netherlands, United States and Germany. Jan D. Bos's co-authors include Marcel B. M. Teunissen, Jan R. Mekkes, Martien L. Kapsenberg, Phyllis I. Spuls, Eddy A. Wierenga, Gamze Pişkin, Menno A. de Rie, Regien M. R. Sylva-Steenland, Patrick M. Bossuyt and Miriam A.M. Loots and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Jan D. Bos

129 papers receiving 8.9k citations

Peers

Countries citing papers authored by Jan D. Bos

Since Specialization

Citations

This map shows the geographic impact of Jan D. Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan D. Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan D. Bos more than expected).

Fields of papers citing papers by Jan D. Bos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan D. Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan D. Bos. The network helps show where Jan D. Bos may publish in the future.

Co-authorship network of co-authors of Jan D. Bos

This figure shows the co-authorship network connecting the top 25 collaborators of Jan D. Bos. A scholar is included among the top collaborators of Jan D. Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan D. Bos. Jan D. Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy 2011 ·Clinical Cancer Research ·Esther P.M. Tjin, Debby Konijnenberg, (unknown), Henk Mallo, Jan W. Drijfhout, Kees L. M. C. Franken, Chantal M.A.M. van der Horst, Jan D. Bos, Omgo E. Nieweg, Bin B. R. Kroon, John B.A.G. Haanen, Cornelis J.M. Melief, Florry A. Vyth‐Dreese, Rosalie M. Luiten	32
2	The Course of Life of Patients with Childhood Atopic Dermatitis 2009 ·Pediatric Dermatology ·Elian E. A. Brenninkmeijer, (unknown), J.H. Sillevis Smitt, Bob F. Last, Martha A. Grootenhuis, Jan D. Bos	65
3	Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients 2009 ·Journal of Investigative Dermatology ·Jasper G. van den Boorn, Debby Konijnenberg, Trees A. M. Dellemijn, J.P.W. van der Veen, Jan D. Bos, Cornelis J.M. Melief, Florry A. Vyth‐Dreese, Rosalie M. Luiten	387
4	Cutting Edge: Loss of TLR2, TLR4, and TLR5 on Langerhans Cells Abolishes Bacterial Recognition 2007 ·The Journal of Immunology ·Angelic M.G. van der Aar, Regien M. R. Sylva-Steenland, Jan D. Bos, Martien L. Kapsenberg, Esther C. de Jong, Marcel B. M. Teunissen	165
5	In Vitro and In Situ Expression of IL-23 by Keratinocytes in Healthy Skin and Psoriasis Lesions: Enhanced Expression in Psoriatic Skin 2006 ·The Journal of Immunology ·Gamze Pişkin, Regien M. R. Sylva-Steenland, Jan D. Bos, Marcel B. M. Teunissen	367
6	Long-term management of plaque psoriasis with continuous efalizumab therapy 2006 ·Journal of the American Academy of Dermatology ·Alan Menter, Craig L. Leonardi, Wolfram Sterry, Jan D. Bos, Kim Papp	26
7	Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005 2006 ·Journal of Allergy and Clinical Immunology ·(unknown), (unknown), Kristian Thestrup‐Pedersen, Johannes Ring, Alain Taı̈eb, Jon M. Hanifin, Kevin D. Cooper, Jan D. Bos, Genji Imokawa, T J David, Carlo Gelmetti, Alexander Kapp, Masutaka Furue, Y. De Prost, Ulf Darsow, Thomas Werfel, David J. Atherton, Arnold P. Oranje	22
8	Altered Penetration of Polyethylene Glycols into Uninvolved Skin of Atopic Dermatitis Patients 2006 ·Journal of Investigative Dermatology ·Ivone Jakaša, Maarten M. Verberk, Maria Esposito, Jan D. Bos, Sanja Kežić	92
9	In situ demonstration of CD40‐ and CD154‐positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro 2004 ·The Journal of Pathology ·Marcel C. Pasch, (unknown), Marjan van Meurs, Vera M. R. Heydendael, Jan D. Bos, Jon D. Laman, Syed S. Asghar	11
10	The Burden of Psoriasis Is Not Determined by Disease Severity Only 2004 ·Journal of Investigative Dermatology Symposium Proceedings ·Vera M. R. Heydendael, Corianne A.J.M. de Borgie, Phyllis I. Spuls, Peter Bossuyt, Jan D. Bos, Menno A. de Rie	118
11	Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis 2004 ·Archives of Dermatological Research ·Amber Y. Goedkoop, Menno A. de Rie, Daisy I. Picavet, Maarten C. Kraan, Huib J. Dinant, Arno W. R. van Kuijk, Paul P. Tak, Jan D. Bos, Marcel B. M. Teunissen	22
12	IL-4 Expression by Neutrophils in Psoriasis Lesional Skin upon High-Dose UVB Exposure 2003 ·Dermatology ·Gamze Pişkin, Ümit Türsen, Jan D. Bos, Marcel B. M. Teunissen	20
13	Ultraviolet B Radiation Induces a Transient Appearance of IL-4+ Neutrophils, Which Support the Development of Th2 Responses 2002 ·The Journal of Immunology ·Marcel B. M. Teunissen, Gamze Pişkin, Sergio Di Nuzzo, Regien M. R. Sylva-Steenland, Menno A. de Rie, Jan D. Bos	72
14	Defensins and complement systems from the perspective of skin immunity and autoimmunity 2001 ·Clinics in Dermatology ·Jan D. Bos, Marcel C. Pasch, Syed S. Asghar	22
15	Dermal Organization in Scleroderma: The Fast Fourier Transform and the Laser Scatter Method Objectify Fibrosis in Nonlesional as well as Lesional Skin 2000 ·Laboratory Investigation ·Henry J.C. de Vries, (unknown), Jan van Marle, Paul P. M. van Zuijlen, Jan R. Mekkes, Jan D. Bos	53
16	Synthesis of Complement Components C3 and Factor B in Human Keratinocytes is Differentially Regulated by Cytokines 2000 ·Journal of Investigative Dermatology ·Marcel C. Pasch, (unknown), Jan D. Bos, Syed S. Asghar, (unknown)	60
17	Interleukin-17 and Interferon-γ Synergize in the Enhancement of Proinflammatory Cytokine Production by Human Keratinocytes 1998 ·Journal of Investigative Dermatology ·Marcel B. M. Teunissen, Jan D. Bos, (unknown), René de Waal Malefyt, Eddy A. Wierenga	469
18	The Poikiloderma of Rothmund-Thomson Syndrome: Changes in Langerhans Cell Morphology and Distribution 1989 ·Dermatology ·(unknown), (unknown), J. W. E. Oorthuys, (unknown), Jan D. Bos	5
19	The restrictive role of sialic acid in antigen presentation to a subset of human peripheral cd4⁺ t lymphocytes that requires antigen‐presenting dendritic cells 1989 ·European Journal of Immunology ·Martien L. Kapsenberg, Frank Stiekema, (unknown), Jan D. Bos, Robert C. Roozemond	19
20	An outbreak of contact dermatitis from toluenesulfonamide formaldehyde resin in a nail hardener 1988 ·Contact Dermatitis ·(unknown), Anton C. de Groot, J. Willem Weyland, Jan D. Bos	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact